tm logo
MONSPHERE
Live/Registered
REGISTERED

on 28 Nov 2023

Serial Number

79358521 filed on 10th Feb 2022

Registration Number

7227089 registered on 28th Nov 2023

in the Principal Register

Correspondent Address

Michael F. Swartz

Michael F. Swartz

1001 Texas Ave., Suite 1250

Houston,TX 77002

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MONSPHERE

Surgical and medical apparatus and instruments for the treatment of cancer, radiological apparatus for medical purposes, radiology screens for medical purposes, namely, radiation shields for protection against X-rays for medical purposes; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the b Read More

Classification Information


Class [010]
Medical Instrument Products


Surgical and medical apparatus and instruments for the treatment of cancer, radiological apparatus for medical purposes, radiology screens for medical purposes, namely, radiation shields for protection against X-rays for medical purposes; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body for the treatment of cancer; drug delivery embolisation apparatus, instruments and systems; medical apparatus and instruments for embolisation for the treatment of cancer; beads, impregnated with radioactive material or radioactive pharmaceutical preparations; microscopic glass beads being medical devices impregnated with radioactive material or radioactive pharmaceutical preparations and administered surgically for treatment of cancerous tumors; glass beads being medical devices containing radioactive material for the treatment of cancerous tumors; glass beads being medical devices containing radioactive pharmaceutical preparations for the treatment of cancerous tumors; implantable radiation therapy devices consisting of radioactive beads, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads for treatment of cancerous tumours; radioactive beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical device, apparatus and instruments for treating cancer; Surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments, namely, a drug delivery system comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation for the treatment of cancer; surgical and medical apparatus and instruments for use in the circulatory system for the treatment of cancer; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues for the treatment of cancer; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment for the treatment of cancer; surgical and medical devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles for treating cancer; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treating cancer; medical devices for ablating human and animal tissue using microwave energy for treating cancer; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts thereforfor all the aforesaid goods; medical apparatus and instruments, namely, beads impregnated with radioactive material for treatment of cancerous tumors, beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumours, beads containing radioactive material, glass beads containing radioactive pharmaceutical preparations, and microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumors, beads in the nature of microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumours

Class [005]
Pharmaceutical Products


Pharmaceuticals preparations for the treatment and prevention of cancer; Medical preparations for the treatment of cancer and cancerous tumors; Veterinary preparations for cancer and cancerous tumors for animals; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer for medical and veterinary purposes; Ginseng capsules for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for the diagnosis of pregnancy for medical and pharmaceutical purposes; chemical preparations for sanitary purposes for veterinary purposes; chemicopharmaceutical preparations for the treatment of cancer; Drug delivery agents in the form of beads, pills, liquid, capsules, dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of a coating for drug and pharmaceuticals preparations that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of circulatory diseases; pharmaceutical preparations for embolization for the treatment of blood vessels; pharmaceutical preparations for embolization of tumours and arteriovenous malformations (AVMs) for the treatment of circulatory conditions; pharmaceutical preparations for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medical purposes, vaccine adjuvants and adjuvants for use with vaccines; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations for the treatment of the circulatory system, vaccines and Antitoxic sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; diagnostic preparations for medical purposes; radioactive substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer; radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; pharmaceutical preparations in the form of particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; pharmaceutical preparations in the form of microcapsules and microparticles adapted to selectively deliver radioactivity to a target for the treatment of cancer; pharmaceutical preparations in the form of microscopic particles and microcapsules for the treatment of cancer and other diseased cells; pharmaceutical preparations in the form of microscopic particles adapted to selectively deliver radioactive material to a target site such as a cell or organ for the treatment of cancer

Mark Details


Serial Number

No 79358521

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2808-40

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Apr 2024FINAL DECISION TRANSACTION PROCESSED BY IB
02th Mar 2024GENERIC MADRID TRANSACTION SENT TO IB
01st Mar 2024GENERIC MADRID TRANSACTION CREATED
28th Feb 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28th Nov 2023REGISTERED-PRINCIPAL REGISTER
28th Nov 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
25th Sep 2023NOTIFICATION PROCESSED BY IB
12th Sep 2023PUBLISHED FOR OPPOSITION
12th Sep 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Sep 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB